Jennifer L Ersek1,2, Jan M Eberth1,3, Karen Kane McDonnell4, Scott M Strayer5, Erica Sercy3, Kathleen B Cartmell6, Daniela B Friedman3,7. 1. Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina. 2. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. 3. Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina. 4. College of Nursing, University of South Carolina, Columbia, South Carolina. 5. Department of Family Medicine, University of South Carolina, Columbia, South Carolina. 6. College of Nursing, Medical University of South Carolina, Charleston, South Carolina. 7. Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, South Carolina.
Abstract
BACKGROUND: The results of the National Lung Screening Trial showed a 20% reduction in lung cancer mortality and a 6.7% reduction in all-cause mortality when high-risk patients were screened with low-dose computed tomography (LDCT) versus chest x-ray (CXR). The US Preventive Services Task Force has issued a grade B recommendation for LDCT screening, and the Centers for Medicare and Medicaid Services and private insurers now cover the screening cost under certain conditions. The purpose of this study was to assess the knowledge of, attitudes toward, and use of LDCT screening for lung cancer among family physicians. METHODS: A 32-item questionnaire was distributed to members of the South Carolina Academy of Family Physicians in 2015. Descriptive statistics were calculated. RESULTS: There were 101 respondents, and most had incorrect knowledge about which organizations recommended screening. Many physicians continued to recommend CXR for lung cancer screening. Most felt that LDCT screening increased the odds of detecting disease at earlier stages (98%) and that the benefits outweighed the harms (75%). Concerns included unnecessary procedures (88%), stress/anxiety (52%), and radiation exposure (50%). Most physicians discussed the risks/benefits of screening with their patients in some capacity (76%); however, more than 50% reported making 1 or no screening recommendations in the past year. CONCLUSIONS: Most family physicians report discussing LDCT with patients at high risk for lung cancer; however, referrals remain low. There are gaps in physician knowledge about screening guidelines and reimbursement, and this indicates a need for further educational outreach. The development of decision aids may facilitate shared decision-making discussions about screening, and targeted interventions may improve knowledge gaps. Cancer 2016;122:2324-2331.
BACKGROUND: The results of the National Lung Screening Trial showed a 20% reduction in lung cancer mortality and a 6.7% reduction in all-cause mortality when high-risk patients were screened with low-dose computed tomography (LDCT) versus chest x-ray (CXR). The US Preventive Services Task Force has issued a grade B recommendation for LDCT screening, and the Centers for Medicare and Medicaid Services and private insurers now cover the screening cost under certain conditions. The purpose of this study was to assess the knowledge of, attitudes toward, and use of LDCT screening for lung cancer among family physicians. METHODS: A 32-item questionnaire was distributed to members of the South Carolina Academy of Family Physicians in 2015. Descriptive statistics were calculated. RESULTS: There were 101 respondents, and most had incorrect knowledge about which organizations recommended screening. Many physicians continued to recommend CXR for lung cancer screening. Most felt that LDCT screening increased the odds of detecting disease at earlier stages (98%) and that the benefits outweighed the harms (75%). Concerns included unnecessary procedures (88%), stress/anxiety (52%), and radiation exposure (50%). Most physicians discussed the risks/benefits of screening with their patients in some capacity (76%); however, more than 50% reported making 1 or no screening recommendations in the past year. CONCLUSIONS: Most family physicians report discussing LDCT with patients at high risk for lung cancer; however, referrals remain low. There are gaps in physician knowledge about screening guidelines and reimbursement, and this indicates a need for further educational outreach. The development of decision aids may facilitate shared decision-making discussions about screening, and targeted interventions may improve knowledge gaps. Cancer 2016;122:2324-2331.
Authors: Alvie Ahsan; Eva Zimmerman; Elisa Marie Rodriguez; Christy Widman; Deborah Oates Erwin; Frances Georgette Saad-Harfouche; Martin Christopher Mahoney Journal: J Cancer Treat Res Date: 2019-03-11
Authors: Louise M Henderson; Thad S Benefield; S Caitlin Bearden; Daniel S Reuland; Alison T Brenner; Adam O Goldstein; Allison Throneburg; M Patricia Rivera Journal: Ann Am Thorac Soc Date: 2019-08
Authors: Samir Soneji; JaeWon Yang; Nichole T Tanner; Rui Dang; Gerard A Silvestri; William Black Journal: Am J Public Health Date: 2017-08 Impact factor: 9.308
Authors: Anne C Melzer; Sara E Golden; Sarah S Ono; Santanu Datta; Kristina Crothers; Christopher G Slatore Journal: J Gen Intern Med Date: 2019-11-19 Impact factor: 5.128
Authors: Sanja Percac-Lima; Jeffrey M Ashburner; Steven J Atlas; Nancy A Rigotti; Efren J Flores; Salome Kuchukhidze; Elyse R Park Journal: J Immigr Minor Health Date: 2019-12